CircBARD1 suppresses tumor progression driven by H3K18 lactylation-CCNA2 axis in human bladder cancer [0.03%]
环状RNA CircBARD1通过抑制H3K18乳酸化-CCNA2轴驱动的肿瘤进程来抑制人类膀胱癌的发展
Zhenghui Hu,Nan Jiang,Bo Xie et al.
Zhenghui Hu et al.
NUAK1 silencing enhances radiotherapy-induced ferroptosis in locally advanced rectal cancer by impairing Nrf2-driven transcription of GPX4 [0.03%]
沉默NUAK1通过抑制Nrf2介导的GPX4转录以增强放疗诱导的局部晚期直肠癌铁死亡
Zhicheng Zhuang,Bingjie Guan,Ye Wang et al.
Zhicheng Zhuang et al.
Integrated analysis identifies a CXCR6/CD45/PD-1-based risk model for melanoma prognosis and intratumoral CD8+/CD69 + T-cell infiltration correlation [0.03%]
整合分析建立了基于CXCR6/CD45/PD-1的黑色素瘤预后风险模型及肿瘤浸润CD8+/CD69+T细胞的相关性模型
Hai-Yun Wang,Hao-Yang Cai,Ling Deng et al.
Hai-Yun Wang et al.
NR2F2/AGAP2 axis: regulating lipid synthesis to drive AML progression via AMPKα/ACC pathway [0.03%]
NR2F2/AGAP2轴通过AMPKα/ACC途径调节脂质合成以促进AML进展
Qi Xin,Henan Zhang,Zheng Zhao et al.
Qi Xin et al.
Distinct clinical and genomic profiles of braf mutation subtypes in Chinese colorectal cancer: a retrospective cohort study with cross-population validation [0.03%]
中国结直肠癌患者中BRAF突变亚型的临床和基因组特征：基于回顾性队列研究并进行跨人群验证
Wentao Yang,Yi Duan,Xiao Huang et al.
Wentao Yang et al.
B3GNT3 facilitates NFKB2 processing and non-canonical NF-κB activation to drive lung adenocarcinoma progression [0.03%]
B3GNT3促进NFKB2加工和非经典NF-κB激活以驱动肺腺癌进展
Ying Lin,Yao Zhang,Bo Yu et al.
Ying Lin et al.
Single-cell transcriptomic mapping of patient-derived primary liver cancer organoids reveals molecular subtypes and guides precision drug targeting [0.03%]
单细胞转录组揭示肝癌分子亚型并指导精准药物治疗
Shipeng Dai,Jian Wu,Yue Chai et al.
Shipeng Dai et al.
Hepatocellular carcinoma and vitamin D metabolism: novel targets and therapeutic strategies [0.03%]
肝细胞癌和维生素D代谢：新靶点和治疗策略
Hanlin Gao,Li He,Zhi Chen et al.
Hanlin Gao et al.
Yulan Kui,Fan Tong,Ruiguang Zhang et al.
Yulan Kui et al.
Abstract: In recent years, cancer immunotherapy has become one of the most important methods in cancer treatment, which can kill tumors by activating the immune system. The PD-1/PD-L1 immune checkpoint signaling pathway i...
Peripheral blood immune cell subsets as non-invasive biomarkers of colorectal cancer stage, laterality, metastasis and survival [0.03%]
外周血免疫细胞亚群作为结直肠癌临床分期、侧向 R0 切除术、转移和生存的无创生物标志物
Julia Del Prado-Montero,Ramón Cantero-Cid,Jenny Guevara-Martínez et al.
Julia Del Prado-Montero et al.
Purpose: Colorectal cancer (CRC) is a heterogeneous disease in which immune dynamics critically influence tumour progression and patient outcomes; however, the relationship between circulating immune cell subsets, immune ...